Date:3/4/2013

atories, 2012
Table 5.10 Charles River Laboratories Revenue ($bn), 2006-2011
Table 5.11 Charles River Laboratories Revenue ($bn) by Business Segment, 2009-2011
Table 5.12 Charles River Laboratories: cGMP Vaccine Manufacturing and Testing Capabilities, 2012
Table 5.13 Lonza: Custom Manufacturing Revenue ($bn), 2009-2011
Table 5.14 Meridian Bioscience & Meridian Life Science: Revenue ($m), 2009-2012
Table 5.15 SAFC Revenue ($m), AGR (%), 2007-2011
Table 5.16 SynCo Bio Partners Capabilities, 2012
Table 6.1 Leading National Vaccine Manufacturing Technology and Services Revenue Forecasts ($bn), AGR (%), CAGR (%), 2011-2017
Table 6.2 Leading National Vaccine Manufacturing Technology and Services Revenue Forecasts ($bn), AGR (%), CAGR (%), 2017-2023
Table 6.3 Vaccine Manufacturing Technology and Services: World Market Shares by Region (%), 2011, 2017 & 2023
Table 6.4 The US Drug Vaccine Manufacturing Technology and Services Forecast ($bn), AGR (%), CAGR (%), 2011-2017
Table 6.5 The US Vaccine Manufacturing Technology and Services Forecast ($bn), AGR (%), CAGR (%), 2017-2023
Table 6.6 EU5 Vaccine Manufacturing Technology and Services Forecasts ($bn), AGR (%), CAGR (%), 2011-2017
Table 6.7 EU5 Vaccine Manufacturing Technology and Services Forecasts ($bn), AGR (%), CAGR (%), 2017-2023
Table 6.8 Vaccine Manufacturing Technology and Services: EU5 Market Shares by Region (%), 2011, 2017 & 2023
Table 6.9 The German Vaccine Manufacturing Technology and Services Forecast ($bn), AGR (%), CAGR (%), 2011-2017
Table 6.10 The German Vaccine Manufacturing Technology and Services Forecast ($bn), AGR (%), CAGR (%), 2017-2023
Table 6.11 The French Vaccine Manufacturing Technology and Services Forecast ($bn), AGR (%), CAGR (%), 2011-2017
Table 6.12 The French Vaccine Manufacturing Technology and Services Forecast ($bn), AGR (%), CAGR (%), 2017-2023
Table 6.13 The UK Vaccine Manufacturing Technology an
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine technology :

1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. Shingles Vaccine is Safe, According to New Study
3. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
4. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
5. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
6. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
7. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
8. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
9. Global Human Vaccines Industry
10. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
11. HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs Second Generation HIV Vaccine